Supplier log in
Request for Information on anti-Diabetic Agents
Details
|
Tender Closed
|
|
| RFx ID : | 8809597 |
| Tender Name : | Request for Information on anti-Diabetic Agents |
| Reference # : | A758873 |
| Open Date : | Thursday, 12 February 2015 12:00 PM (Pacific/Auckland UTC+13:00) |
| Close Date : | Thursday, 12 March 2015 5:00 PM (Pacific/Auckland UTC+13:00) |
| Tender Type : | Request for Information (Market research) (RFI) |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Required Pre-qualifications : | None |
| Contact : |
Bronwyn Hale bronwyn.hale@pharmac.govt.nz |
| Alternate Physical Delivery Address : | |
| Alternate Physical Fax Number : | |
| Agency Address : | |
PHARMAC is interested in receiving information from suppliers, clinicians and diabetes healthcare professionals in respect of the following classes of anti-diabetic agents:
a. dipeptidyl peptidase4 inhibitors (DPP4-inhibitors);
b. glucagon-like peptide-1 agonists (GLP-1s);
c. sodium glucose co-transporter 2 inhibitors (SGLT-2s); and
d. combination anti-diabetic agents (e.g. DPP4-inhibitors/metformin).
The purpose of this request for information (RFI) is to seek information to inform and assist PHARMAC in determining the most appropriate funding arrangement and process, which may include progressing to a request for proposals (RFP) or other competitive process at a later date.
If you wish to submit a response, you must submit it to PHARMAC by email no later than 5.00 pm on 5 March 2015. Submissions and any questions you might have can be sent to Bronwyn Hale, Therapeutic Group Manager (bronwyn.hale@pharmac.govt.nz).
Further information can be found in the attached document.
This tender has been completed.
Further information:
This was a Request for Information only. No proposals were progressed as part of this process.
Date RFx was completed/updated:
Monday, 21 December 2015 3:53 PM (Pacific/Auckland UTC+13:00)
